We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Studies
Ump3.0
Uridine Monophosphate Research
Mostly mechanism / observational
5 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Uridine Monophosphate studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality meta-analyses and randomised trials published 2008–2025 with a typical study size of 101 participants.
Based on 5 studies · 1 meta-analysis · 1 RCT · 115 total participants
Confidence
Moderate confidence
By outcome
Cognitive functionSmall memory benefit in mild Alzheimer's — but only as part of the uridine + DHA + choline combination (Souvenaid), not standalone UMP · Unknown for standalone; 12-24 weeks in combination trials
Mostly mechanism / observational4 studies
Active research area
2 studies in the last 5 years · Latest meta-analysis: 2017
200820162025
1RCTn=14 · very small study2025
Subramaniyan M, Vital-Lopez FG, Doty TJ, Anlap I, Killgore WDS, Reifman J. · Sleep (2025)
Conclusions As a proof of principle, we developed a practical approach for predicting an individual's alertness impairment using passively recorded facial videos.
In plain English: Conclusion The use of dietary supplement Neururidine N is an effective and safe method of coanalgesic therapy in patients with acute LBP.
Yakupov EZ, Burd SG, Barantsevich ER, Gamieva RA, Mendel OI, Lebedeva AV, Rubleva YV, Pantina NV, Bokitko TA, Kovaleva II, Bogomazova MA, Efimenko AP, Smochilin AG. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)
In patients of group 1, an earlier improvement in functional status was noted (starting from day 7) according to ORM data ( p <0.01), A more pronounced decrease in pain intensity allowed patients of group 1 to stop taking NSAIDs after 14 days ( p <0.01).
Patients of the 1 st group were statistically significantly more satisfied with the results of treatment (CGI questionnaire), the doctors who observed them also regarded the improvement in their condition as more significant compared to the 2 nd group.
Results The positive effect of treatment on reducing the severity of pain was noted according to the results of the VAS assessment.
In plain English: Across three RCTs, the uridine-monophosphate-containing medical food Souvenaid achieved small but clinically detectable memory effects in mild Alzheimer's, with no cognitive effect in mild-to-moderate disease.
Cummings J, Scheltens P, McKeith I, et al. · J Alzheimers Dis (2017)
Effect size ~0.20-0.21 on memory outcomes in mild AD (Souvenir I and II)
No effect on cognition in mild-to-moderate AD (S-Connect)
Effect is for the COMBINATION (uridine monophosphate + DHA + EPA + choline + phospholipids + B-vitamins), not standalone uridine
In plain English: In memory-impaired rats, dietary uridine monophosphate or DHA improved water-maze performance, and combining the two enhanced it further while raising brain phospholipid levels.
Holguin S, Huang Y, Liu J, Wurtman R. · Behav Brain Res (2008)
Dietary UMP or gavaged DHA each improved hippocampal-dependent memory in impoverished rats (p < 0.05)
Co-administration of UMP + DHA further enhanced performance (p < 0.001)
UMP + DHA increased brain phosphatidylcholine and total phospholipid levels
In plain English: Only the Fortasyn diet — fish oil plus uridine-monophosphate, choline, B-vitamins and cofactors — alleviated the spatial-learning deficit in Alzheimer-model mice.